Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting
Enovis Corporation (NYSE: ENOV) has been awarded the Industry Innovation Award at the American Academy of Hip and Knee Surgeons (AAHKS) Annual Meeting for its ARVIS Augmented Reality Surgical Guidance System. This groundbreaking AR technology allows orthopedic surgeons to visualize precision guidance during hip and knee surgeries. Unlike large robotic systems, ARVIS is FDA-cleared and designed for easy adoption in surgical centers, providing more patients access to advanced surgical options. Enovis aims to enhance patient outcomes with ongoing innovations.
- ARVIS wins the Industry Innovation Award from AAHKS, enhancing brand recognition.
- ARVIS is FDA-cleared, highlighting compliance and potential for adoption in surgeries.
- The design of ARVIS is economical, making it more accessible to a wider range of surgical facilities.
- None.
Wilmington, DE, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the company’s ARVIS® Augmented Reality Surgical Guidance System received the Industry Innovation Award at the this year’s American Academy of Hip and Knee Surgeons (AAHKS) Annual Meeting. This annual award recognizes cutting-edge innovation in products, procedures and services in the field of Hip and Knee Arthroplasty.
ARVIS is the only FDA-cleared proprietary, real-time, hands-free augmented reality (AR) technology engineered for orthopedic surgeons, so they can visualize precision guidance when performing hip and knee surgery. With its streamlined design, ARVIS has a more economical price and footprint than large robotic systems, so it can be easily adopted and scaled by a wide array of ambulatory surgical centers and hospitals, allowing more access to patients wishing to experience the benefits of a technology assisted knee or hip replacement.
“We are absolutely thrilled to receive this award and be recognized by such a prestigious organization as AAHKS,” said Louie Vogt, President and General Manager, Enovis Surgical™. “ARVIS represents the next era of orthopedic technology and we look forward to continuing to expand our feature set and capabilities to improve patient care and outcomes with cutting-edge innovation in the future.”
ARVIS is compatible with Enovis’ innovative EMPOWR™ Hip and Knee product offerings, including EMPOWR™ 3D, Porous and Partial Knee, EMPOWR Acetabular® and Dual Mobility, along with compatible femoral stems.
For more information, visit enovis.com/arvis.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.
Media Contact:
Cristina Pasquino
Communications Manager
Enovis Corporation
+1-772-382-9121
Cristina.Pasquino@enovis.com
Source: Enovis Corporation
Attachment
FAQ
What is the ARVIS Augmented Reality Surgical Guidance System by Enovis?
When did Enovis announce the Industry Innovation Award for ARVIS?
What does the Industry Innovation Award signify for Enovis?
How does ARVIS compare to traditional robotic systems?
Is ARVIS compatible with other Enovis products?
